Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients

Several reports described an increased risk of cardiovascular (CV) events, mainly atherothrombotic, in Chronic Myeloid Leukemia (CML) patients receiving nilotinib. However, the underlying mechanism remains elusive. The objective of the current cross-sectional retrospective study is to address a pote...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Oncotarget
المؤلفون الرئيسيون: Bocchia, Monica, Galimberti, Sara, Aprile, Lara, Sicuranza, Anna, Gozzini, Antonella, Santilli, Francesca, Abruzzese, Elisabetta, Baratè, Claudia, Scappini, Barbara, Fontanelli, Giulia, Trawinska, Monika Malgorzata, Defina, Marzia, Gozzetti, Alessandro, Bosi, Alberto, Petrini, Mario, Puccetti, Luca
التنسيق: Artigo
اللغة:Inglês
منشور في: Impact Journals LLC 2016
الموضوعات:
Clinical Research Paper
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342164/
https://ncbi.nlm.nih.gov/pubmed/27527867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11100
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة